Nutritional Intervention in Geriatric Oncology (INOGAD)
Primary Purpose
Cancer, Undernutrition, Aging
Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
nutritional intervention with dietician plus usual nutritional care
usual nutritional care
Sponsored by
About this trial
This is an interventional prevention trial for Cancer focused on measuring Cancer, elderly, malnutrition, chemotherapy, survival, comprehensive geriatric assessment, morbidity
Eligibility Criteria
Inclusion Criteria:
- Over 70 years of age
- Histologically proven cancer
- Treatment by chemotherapy
- Risk of undernutrition according to MNA score between 17 and 23.5
- ECOG ≤ 3
- Life expectancy > 12 weeks
- Patient affiliated with the French social security regimen
- Written informed consent
Exclusion Criteria:
- MNA score under 17 or over 23.5
- Geographic, psychological, or social conditions potentially hampering compliance with the study protocol
- Symptomatic central nervous system (CNS) metastases
- Chemotherapy treatments not published as standard protocols
- Treatment that does not allow geriatric evaluation and dietician follow-up.
Sites / Locations
- Institut Bergonié - 229 Cours de l'Argonne
- Pôle de Gériatrie - CHU Bordeaux-Hôpital Xavier Arnozan - Avenue du Haut-Lévèque
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
1
2
Arm Description
nutritional intervention with dietician at each cycle of chemotherapy in 6 first cycles to maintain 30 kcal/kg/d and 1.2 protein/kg/d
Outcomes
Primary Outcome Measures
Survival
Secondary Outcome Measures
Survival
toxicity of chemotherapy (NTC CTCv3 scale)
quality of life
biology (C-reactive protein [CRP], albumin, haemoglobin, creatinine clearance)
mood (GDS-15)
function: IADL, ADL, get up and go test
weight
MNA
dietary intakes
hospitalisation frequency
opportunistic infection frequency
fall, breaks, pressure sore
death
Full Information
NCT ID
NCT00459589
First Posted
April 11, 2007
Last Updated
June 19, 2012
Sponsor
University Hospital, Bordeaux
Collaborators
Ministry of Health, France, Ligue contre le cancer, France
1. Study Identification
Unique Protocol Identification Number
NCT00459589
Brief Title
Nutritional Intervention in Geriatric Oncology
Acronym
INOGAD
Official Title
Nutritional Intervention in Geriatric Oncology in Patients at Risk of Undernutrition
Study Type
Interventional
2. Study Status
Record Verification Date
June 2012
Overall Recruitment Status
Completed
Study Start Date
April 2007 (undefined)
Primary Completion Date
March 2012 (Actual)
Study Completion Date
March 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Bordeaux
Collaborators
Ministry of Health, France, Ligue contre le cancer, France
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Older patients with cancer are poorly treated or not treated at all. A previous study in the south west of France (364 patients) showed that patients receiving chemotherapy had short survival times which strongly depended on nutritional status. In this study, the researchers would like to evaluate if individual dietician follow-up at each cycle of chemotherapy increases survival of patients at risk of undernutrition.
Detailed Description
Undernutrition in patients with cancer also called tumour cachexia concerns about 50% of this population during tumour progression. It's well established that loss of weight is poor prognosis factor in patients treated by chemotherapy in digestive cancers. Small number of studies assessing undernutrition, its management and consequences on prognosis were published. Previous study lead by our team in oncogeriatry in Aquitaine accrued 364 patients more than 70 years old and treated by chemotherapy for cancer. Median follow-up at 13 months for intermediary analysis about 155 first patients revealed at first geriatric evaluation, 28 pts (18.7%) were malnourished (MNA<17) and 72 pts (48.0%) at risk of malnutrition (MNA 17 to 23.5). At one year median follow-up major mortality was observed in 20 (71.4%) undernourished patients, 34 (47.2%) patients at risk of undernutrition and 13 (26.0%) patients without nutritional problem. According to consensus undernourished patients received nutritional support. Management of patients at risk of malnutrition is not clear. Our hypothesis is that nutritional support in patients at risk of undernutrition detected during geriatric evaluation could increase survival, safety, functional status and quality of life of patients. We construct an open multicentric two group randomized trial comparing usual nutritional management versus usual nutritional management plus nutritional intervention with dietician at each cycle of chemotherapy in 6 first cycles to maintain 30 kcal/kg/d and 1.2 protein/kg/d. Principal objective is to increase survival at 1 year with 10%. According to O'Brien and Fleming method we have to include 410 pts in each group, about 1640 pts will be evaluated by MNA test.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cancer, Undernutrition, Aging
Keywords
Cancer, elderly, malnutrition, chemotherapy, survival, comprehensive geriatric assessment, morbidity
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
341 (Actual)
8. Arms, Groups, and Interventions
Arm Title
1
Arm Type
Experimental
Arm Description
nutritional intervention with dietician at each cycle of chemotherapy in 6 first cycles to maintain 30 kcal/kg/d and 1.2 protein/kg/d
Arm Title
2
Arm Type
Active Comparator
Intervention Type
Behavioral
Intervention Name(s)
nutritional intervention with dietician plus usual nutritional care
Intervention Description
nutritional intervention with dietician at each cycle of chemotherapy in 6 first cycles to maintain 30 kcal/kg/d and 1.2 protein/kg/d
Intervention Type
Behavioral
Intervention Name(s)
usual nutritional care
Intervention Description
usual nutritional care
Primary Outcome Measure Information:
Title
Survival
Time Frame
1 year
Secondary Outcome Measure Information:
Title
Survival
Time Frame
2 years
Title
toxicity of chemotherapy (NTC CTCv3 scale)
Time Frame
within 6 cycles of chemotherapy treatment,
Title
quality of life
Time Frame
before and after chemotherapy treatment
Title
biology (C-reactive protein [CRP], albumin, haemoglobin, creatinine clearance)
Time Frame
before and after treatment
Title
mood (GDS-15)
Time Frame
before and after treatment
Title
function: IADL, ADL, get up and go test
Time Frame
before and after treatment
Title
weight
Time Frame
before and after treatment
Title
MNA
Time Frame
before and after treatment
Title
dietary intakes
Time Frame
before and after treatment
Title
hospitalisation frequency
Time Frame
during treatment
Title
opportunistic infection frequency
Time Frame
during treatment
Title
fall, breaks, pressure sore
Time Frame
during treatment
Title
death
Time Frame
during treatment and at 2 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Over 70 years of age
Histologically proven cancer
Treatment by chemotherapy
Risk of undernutrition according to MNA score between 17 and 23.5
ECOG ≤ 3
Life expectancy > 12 weeks
Patient affiliated with the French social security regimen
Written informed consent
Exclusion Criteria:
MNA score under 17 or over 23.5
Geographic, psychological, or social conditions potentially hampering compliance with the study protocol
Symptomatic central nervous system (CNS) metastases
Chemotherapy treatments not published as standard protocols
Treatment that does not allow geriatric evaluation and dietician follow-up.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Isabelle BOURDEL MARCHASSON, Pr.
Organizational Affiliation
University Hospital, Bordeaux, France
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Geneviève CHENE, Pr.
Organizational Affiliation
University Hospital, Bordeaux, France
Official's Role
Study Chair
Facility Information:
Facility Name
Institut Bergonié - 229 Cours de l'Argonne
City
Bordeaux
ZIP/Postal Code
33076
Country
France
Facility Name
Pôle de Gériatrie - CHU Bordeaux-Hôpital Xavier Arnozan - Avenue du Haut-Lévèque
City
Pessac
ZIP/Postal Code
33604
Country
France
12. IPD Sharing Statement
Citations:
PubMed Identifier
25265392
Citation
Bourdel-Marchasson I, Blanc-Bisson C, Doussau A, Germain C, Blanc JF, Dauba J, Lahmar C, Terrebonne E, Lecaille C, Ceccaldi J, Cany L, Lavau-Denes S, Houede N, Chomy F, Durrieu J, Soubeyran P, Senesse P, Chene G, Fonck M. Nutritional advice in older patients at risk of malnutrition during treatment for chemotherapy: a two-year randomized controlled trial. PLoS One. 2014 Sep 29;9(9):e108687. doi: 10.1371/journal.pone.0108687. eCollection 2014.
Results Reference
derived
Learn more about this trial
Nutritional Intervention in Geriatric Oncology
We'll reach out to this number within 24 hrs